About Science 37
Science 37 is a company based in Los Angeles (United States) founded in 2014 was acquired by eMed Technologies in January 2024. Science 37 has raised $106.5 million across 4 funding rounds from investors including Amgen, Novartis and PPD. Science 37 offers products and services including Metasite Platform and Patient Recruitment. Science 37 operates in a competitive market with competitors including Medidata, Verily, IQVIA, TriNetX and Signant Health, among others.
- Headquarter Los Angeles, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$106.5 M (USD)
in 4 rounds
-
Latest Funding Round
$40 M (USD), Series D
Aug 20, 2020
-
Investors
Amgen
& 11 more
-
Employee Count
Not available
-
Acquired by
eMed Technologies
(Jan 29, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Science 37
Science 37 offers a comprehensive portfolio of products and services, including Metasite Platform and Patient Recruitment.
Enables remote clinical trials for broader patient access and data collection
Facilitates diverse participant enrollment in clinical studies remotely
People of Science 37
Unlock access to complete
Funding Insights of Science 37
Science 37 has successfully raised a total of $106.5M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $40 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Science 37
Science 37 has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, Novartis and PPD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Locked | Locked | Locked | |
|
Corporate backed venture capital fund investing in multiple sectors
|
Locked | Locked | Locked | |
|
Investments are directed toward early and late-stage tech companies.
|
Locked | Locked | Locked |
Investor details for Science 37
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Science 37
Investment portfolio details for Science 37
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Science 37
Detailed financials for Science 37
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Science 37 Comparisons
Peer comparison for Science 37
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Science 37
Science 37 operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, IQVIA, TriNetX and Signant Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Clinical research and commercialization solutions are provided for healthcare.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
Detailed competitors of Science 37
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Science 37
Complete news archive for Science 37
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Science 37
Science 37 was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Science 37 is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
David Coman is the current CEO of Science 37.
Science 37 is a funded company, having raised a total of $106.5M across 4 funding rounds to date.
Science 37 was founded in 2014 and is headquartered in Los Angeles, United States. Operations focus on the clinical trials sector, where end-to-end solutions are delivered to support researchers. A mobile platform enables patient participation, while tools like Metasite facilitate site-based data collection, trial management, and communication. Additional features include recruitment systems, patient enrollment processes, and virtualization for study design concepts.
Science 37 offers Metasite Platform and Patient Recruitment.
Science 37 has 12 investors. Key investors include Amgen, Novartis, PPD, Mubadala, and eMed Technologies.